Pages that link to "Q282902"
Jump to navigation
Jump to search
The following pages link to naloxone (Q282902):
Displayed 50 items.
- World Health Organization Model List of Essential Medicines (Q37155) (← links)
- toxic shock syndrome (Q1128440) (← links)
- septic shock (Q1765564) (← links)
- (+)-Naloxone (Q4540629) (← links)
- opioid receptor mu 1 (Q5123372) (← links)
- oxycodone/naloxone (Q7115907) (← links)
- opioid receptor kappa 1 (Q8083989) (← links)
- Opioid receptor, kappa 1 (Q14900999) (← links)
- Opioid receptor, mu 1 (Q14911929) (← links)
- (Q16708599) (redirect page) (← links)
- opioid overdose (Q17154378) (← links)
- opiate dependence (Q18555117) (← links)
- Opioid receptor delta 1 (Q21115334) (← links)
- fentanyl toxicity (Q21504884) (← links)
- Opioid receptor, delta 1 (Q21988386) (← links)
- buprenorphine/naloxone (Q25048068) (← links)
- Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies (Q26785478) (← links)
- Developments in managing severe chronic pain: role of oxycodone-naloxone extended release (Q26801140) (← links)
- (+)-naloxone (Q27087836) (← links)
- Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria (Q28075931) (← links)
- Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7 (Q28270611) (← links)
- Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know (Q28365114) (← links)
- The effect of naloxone treatment on opioid-induced side effects: A meta-analysis of randomized and controlled trails (Q33595205) (← links)
- (+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats (Q34269801) (← links)
- Flumazenil, naloxone and the 'coma cocktail'. (Q34498099) (← links)
- Quality of life and healthcare resource in patients receiving opioids for chronic pain: a review of the place of oxycodone/naloxone (Q34798408) (← links)
- Low-dose naloxone provides an abuse-deterrent effect to buprenorphine (Q36265260) (← links)
- Chemiluminescence detection of opium poppy (Papaver somniferum) alkaloids (Q37245329) (← links)
- Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists (Q37309608) (← links)
- Police officer attitudes towards intranasal naloxone training (Q39084936) (← links)
- Comparison of tilidine/naloxone, tramadol and bromfenac in experimental pain: a double-blind randomized crossover study in healthy human volunteers. (Q39436589) (← links)
- Emergency naloxone for heroin overdose: naloxone is not the only opioid antagonist (Q43249025) (← links)
- Reversing tragedy. Proposed legislation will increase access to an antidote to opioid overdose (Q44345104) (← links)
- Evzio (Q47521584) (← links)
- Narcan (Q47521866) (← links)
- Naloxone dosage for opioid reversal: current evidence and clinical implications. (Q48275689) (← links)
- Stopping an Invisible Epidemic: Legal Issues in the Provision of Naloxone to Prevent Opioid Overdose (Q56135457) (← links)
- SOONER Feasibility Study Protocol (Q61700073) (← links)
- State laws and policies to reduce opioid-related harm: A qualitative assessment of PDMPs and naloxone programs in ten U.S. States (Q61811511) (← links)
- Evaluation of Intranasal Naltrexone and Naloxone (Q61865495) (← links)
- Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment (Q61904858) (← links)
- Mobile Intervention for Young Opioid Users (Q61906859) (← links)
- Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF) (Q61907071) (← links)
- XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept (Q61907425) (← links)
- High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid (Q61909547) (← links)
- Safety and Tolerability of Buprenorphine/Naloxone Film Strips (Q61914885) (← links)
- Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone (Q61915278) (← links)
- Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir (Q61918435) (← links)
- Naloxone for the Treatment of Opioid-Induced Pruritus (Q61938730) (← links)
- Drug Discrimination in Methadone-Maintained Humans Study 3 (Q61938993) (← links)